Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Clinical trial NCT04645160 · RECRUITING

Trial details

NCT number: NCT04645160
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Bile Duct Neoplasm Biliary Tract Malignancy

Start date: 2022-03-04
Primary completion: 2028-12-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.